A Phase I Double-Blind, Placebo-Controlled, Single Rising Dose Study to Determine the Safety, Tolerability, and Pharmacokinetics of Oral YM934 in Healthy Male Volunteers

1998 ◽  
Vol 38 (1) ◽  
pp. 45-53 ◽  
Author(s):  
Jacobus Burggraaf ◽  
Rik C. Schoemaker ◽  
Ido J. Terpstra ◽  
Adam F. Cohen
Keyword(s):  
Phase I ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Dose Study

Neutralization of α2-antiplasmin by microplasmin: A randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers

2009 ◽  
Vol 31 (8) ◽  
pp. 1688-1706 ◽  
Author(s):  
Steve Pakola ◽  
Geraldine Cahillane ◽  
Jean-Marie Stassen ◽  
H. Roger Lijnen ◽  
Peter Verhamme
Keyword(s):  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Dose Study

Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study

Endocrine ◽  
2012 ◽  
Vol 42 (2) ◽  
pp. 366-374 ◽  
Author(s):  
Christoph Beglinger ◽  
Ke Hu ◽  
Ying Wang ◽  
Emmanuel Bouillaud ◽  
Christelle Darstein ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Double Blind ◽  
Once Daily ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers

1998 ◽  
Vol 176 (6) ◽  
pp. 27S-31S ◽  
Author(s):  
Claartje H.M van Nispen ◽  
Andy I.M Hoepelman ◽  
Marja Rozenberg-Arska ◽  
Jan Verhoef ◽  
Lynn Purkins ◽  
...  
Keyword(s):  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Parallel Group Study ◽  
Parallel Group
Sign in / Sign up

Export Citation Format

Share Document